Issue: April 2016
April 07, 2016
1 min read
Save

Trial Scorecard: ZEUS

Issue: April 2016
You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Comparison of a zotarolimus-eluting stent to a bare-metal stent in patients with CAD and high risk for bleeding.

Trial Scorecard: ZEUS